From Standard & Poor's Equity ResearchTexas Instruments (TXN
) posted 33 cents, vs. 21 cents, first quarter EPS from continuing operations on a 23% revenue rise. The company sees 38 cents to 43 cents second quarter EPS from continuing operations. S&P raises estimates, maintains strong buy.
Coca-Cola Co. (KO
) posted 47 cents, vs. 42 cents, first quarter EPS (including charges) despite flat sales. THe soft drink outfit plans to buy back $2-$2.5 billion of its stock for the full year.
) posted $2.01, vs. $1.67, first quarter operating EPS on a 4.3% revenue rise. The company raised its $5.60-$6.00 2006 operating EPS guidance to $6.00-$6.40. S&P keeps strong buy. Wachovia upgrades to outperform.
) posted a 49-cent first quarter loss per share, vs. a $1.00 loss, on 13% higher revenue. S&P reiterates strong buy.
JP Morgan Chase (JPM
) posted 86 cents, vs. 63 cents, first quarter EPS on a 12% revenue rise.
) posted 11 cents (including
stock option expense) vs. 14 cents, first quarter EPS as higher costs and expenses offset a 34% revenue rise.
IBM Corp. IBM
) posted $1.08, vs. 84 cents, first quarter EPS despite a 9.8% revenue drop. Big Blue says that excluding PC revenues, first quarter 2006 revenues were flat; adjusted for foreign exchange effects, revenues rose 4%. S&P raised its target and keeps its buy opinion.
) posted 56 cents, vs. 4 cents, first quarter EPS from continuing operations despite a 3% revenue drop. The company says while sales in the first quarter were below estimatess, it continues to pursue its target of more than $13 billion in 2006 revenue for Lipitor. S&P reiterates buy.
Abbott Laboratories (ABT
) posted 56 cents, vs. 53 cents, first quarter EPS (GAAP) as higher selling, general, and administrative costs offset a 3.7% sales drop. The pharma outfit orecasts 59-61 cents second quarter EPS, excluding special items.
United Technologies (UTX
) posted 76 cents, vs. 64 cents, first quarter EPS on 13% higher consolidated revenue. Thje conglomerate raised its 2006 EPS guidance to $3.50-$3.60 from its prior $3.40-$3.55 outlook.
Schering AG (SHR
) reported a 12% increase in first quarter organic net sales, and expects ??240M net operating profit.
CBOT Holdings (BOT
) posted 47 cents (including charges), vs. 5 cents, first quarter EPS (GAAP) on sharply higher revenue. The company plans a $150 million stock buyback.
) posted 34% higher fourth quarter net income on a 33% revenue rise.
St. Jude Medical (STJ
) posted 36 cents, vs. 32 cents, first quarter EPS on an 18% sales rise. The medical device maker set a $700 million stock buyback.